Antithrombins deactivate several enzymes of coagulation system to prevent excessive blood clots. Growing use of antithrombin in conjunction with heparin due to the increased reporting of diseases like sepsis, intravascular coagulations, and myocardial infractions, high incidences of coagulation disorders, increased rates of kidney and heart failure (used extensively in dialysis and open-heart...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian